首页 > 最新文献

Middle East African Journal of Ophthalmology最新文献

英文 中文
Bilateral Acute Iris Transillumination Following Coronavirus Disease 2019 Infection. 2019年冠状病毒病感染后的双侧急性虹膜透亮。
IF 0.5 Q4 OPHTHALMOLOGY Pub Date : 2024-09-13 eCollection Date: 2023-07-01 DOI: 10.4103/meajo.meajo_69_24
Abdulrahman F Albloushi, Ghada Alabdi, Hend Elmutawi

Bilateral acute iris transillumination (BAIT) syndrome is an uncommon disorder marked by sudden dispersion of pigment in the anterior chamber, iris sphincter muscle paralysis, and elevated intraocular pressure. This syndrome has been linked to viral infections and the administration of fluoroquinolones such as moxifloxacin. This study presents a case of a 54-year-old male, otherwise in good health, who developed BAIT syndrome 1 week after experiencing an upper respiratory tract infection that followed a coronavirus disease 2019 (COVID-19) diagnosis. The patient was effectively treated with topical prednisolone acetate and antiglaucoma medications. Further studies are required to investigate the relationship between COVID-19 and BAIT to enhance understanding of its pathophysiology.

双侧急性虹膜透光综合征(BAIT)是一种不常见的疾病,其特征是前房色素突然消散、虹膜括约肌麻痹和眼压升高。这种综合征与病毒感染和服用氟喹诺酮类药物(如莫西沙星)有关。本研究介绍了一例 54 岁男性患者的病例,该患者健康状况良好,在被诊断为冠状病毒病 2019(COVID-19)后出现上呼吸道感染,1 周后出现 BAIT 综合征。患者接受了醋酸泼尼松龙外用药和抗青光眼药物的有效治疗。需要进一步研究 COVID-19 与 BAIT 之间的关系,以加深对其病理生理学的了解。
{"title":"Bilateral Acute Iris Transillumination Following Coronavirus Disease 2019 Infection.","authors":"Abdulrahman F Albloushi, Ghada Alabdi, Hend Elmutawi","doi":"10.4103/meajo.meajo_69_24","DOIUrl":"https://doi.org/10.4103/meajo.meajo_69_24","url":null,"abstract":"<p><p>Bilateral acute iris transillumination (BAIT) syndrome is an uncommon disorder marked by sudden dispersion of pigment in the anterior chamber, iris sphincter muscle paralysis, and elevated intraocular pressure. This syndrome has been linked to viral infections and the administration of fluoroquinolones such as moxifloxacin. This study presents a case of a 54-year-old male, otherwise in good health, who developed BAIT syndrome 1 week after experiencing an upper respiratory tract infection that followed a coronavirus disease 2019 (COVID-19) diagnosis. The patient was effectively treated with topical prednisolone acetate and antiglaucoma medications. Further studies are required to investigate the relationship between COVID-19 and BAIT to enhance understanding of its pathophysiology.</p>","PeriodicalId":18740,"journal":{"name":"Middle East African Journal of Ophthalmology","volume":"30 3","pages":"185-187"},"PeriodicalIF":0.5,"publicationDate":"2024-09-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11495286/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142504330","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Visual Outcome and Complications in White Mature Cataracts after Phacoemulsification. 白内障超声乳化术后的视觉效果和并发症
IF 0.5 Q4 OPHTHALMOLOGY Pub Date : 2024-09-13 eCollection Date: 2023-07-01 DOI: 10.4103/meajo.meajo_100_23
Komal Jaiswal, Rishabh Rathi, Amisha Jain, Ashish Gaur, Nitin Nema

Purpose: To identify risk factors and perioperative complications and assess postoperative visual outcome in patients of white mature cataracts undergoing phacoemulsification surgery.

Methods: This cross-sectional study was conducted on 46 patients of white mature cataract undergoing phacoemulsification. Preoperatively, a detailed ocular examination was done, and anterior chamber depth (ACD) and lens thickness (LT) were measured on ultrasound biomicroscopy. Intraoperative and postoperative complications (on days 1, 7, and 30) and best-corrected visual acuity on postoperative day 30 were noted.

Results: The mean age of patients was 60.78 ± 9.001 years. The study group consisted of 41.3% of males and 58.7% of females. 8 (19.56%) cases encountered complications during phacoemulsification surgery. The intraoperative complications were capsulorhexis-related in 5 (10.86%) patients, posterior capsular rent in 2 (4.3%) patients, and 1 (2.17%) case had zonular dialysis. There was no difference in mean ACD and LT in cases who developed complications and those who underwent uneventful surgery (P > 0.05). The commonly observed postoperative complications on day 1 were corneal edema (41.3%), anterior chamber flare (45.65%), and cells (39.13%) which resolved with routine topical medications. All patients showed a significant reduction in postoperative intraocular pressure (P < 0.001). A total of 37 (80.43%) eyes regained vision between 6/6 and 6/9 postoperatively (P < 0.001).

Conclusion: Phacoemulsification surgery is safe in white mature cataract that results in significant visual improvement. Common intraoperative complications are capsule related, while frequently encountered postoperative complications are corneal edema and anterior chamber reaction. Preoperative ACD and LT have no role in predicting intraoperative complications.

目的:确定接受超声乳化手术的白色成熟白内障患者的风险因素和围手术期并发症,并评估术后视觉效果:这项横断面研究针对 46 名接受超声乳化手术的白色成熟白内障患者。术前进行了详细的眼部检查,并通过超声生物显微镜测量了前房深度(ACD)和晶状体厚度(LT)。记录了术中和术后并发症(第 1、7 和 30 天)以及术后第 30 天的最佳矫正视力:患者平均年龄(60.78±9.001)岁。研究组中男性占 41.3%,女性占 58.7%。8例(19.56%)患者在乳化手术中出现并发症。5例(10.86%)患者的术中并发症与囊膜脱落有关,2例(4.3%)患者出现后囊膜脱落,1例(2.17%)患者出现虹膜透析。出现并发症的病例与手术顺利的病例在平均 ACD 和 LT 方面没有差异(P > 0.05)。术后第 1 天常见的并发症是角膜水肿(41.3%)、前房外翻(45.65%)和细胞(39.13%),这些并发症在常规局部用药后即可缓解。所有患者的术后眼压都有明显下降(P < 0.001)。共有 37 只眼睛(80.43%)在术后视力恢复到 6/6 到 6/9 之间(P < 0.001):结论:对于白内障患者来说,超声乳化手术是安全的,能显著改善视力。术中常见的并发症与囊袋有关,而术后常见的并发症是角膜水肿和前房反应。术前ACD和LT在预测术中并发症方面没有作用。
{"title":"Visual Outcome and Complications in White Mature Cataracts after Phacoemulsification.","authors":"Komal Jaiswal, Rishabh Rathi, Amisha Jain, Ashish Gaur, Nitin Nema","doi":"10.4103/meajo.meajo_100_23","DOIUrl":"https://doi.org/10.4103/meajo.meajo_100_23","url":null,"abstract":"<p><strong>Purpose: </strong>To identify risk factors and perioperative complications and assess postoperative visual outcome in patients of white mature cataracts undergoing phacoemulsification surgery.</p><p><strong>Methods: </strong>This cross-sectional study was conducted on 46 patients of white mature cataract undergoing phacoemulsification. Preoperatively, a detailed ocular examination was done, and anterior chamber depth (ACD) and lens thickness (LT) were measured on ultrasound biomicroscopy. Intraoperative and postoperative complications (on days 1, 7, and 30) and best-corrected visual acuity on postoperative day 30 were noted.</p><p><strong>Results: </strong>The mean age of patients was 60.78 ± 9.001 years. The study group consisted of 41.3% of males and 58.7% of females. 8 (19.56%) cases encountered complications during phacoemulsification surgery. The intraoperative complications were capsulorhexis-related in 5 (10.86%) patients, posterior capsular rent in 2 (4.3%) patients, and 1 (2.17%) case had zonular dialysis. There was no difference in mean ACD and LT in cases who developed complications and those who underwent uneventful surgery (<i>P</i> > 0.05). The commonly observed postoperative complications on day 1 were corneal edema (41.3%), anterior chamber flare (45.65%), and cells (39.13%) which resolved with routine topical medications. All patients showed a significant reduction in postoperative intraocular pressure (<i>P</i> < 0.001). A total of 37 (80.43%) eyes regained vision between 6/6 and 6/9 postoperatively (<i>P</i> < 0.001).</p><p><strong>Conclusion: </strong>Phacoemulsification surgery is safe in white mature cataract that results in significant visual improvement. Common intraoperative complications are capsule related, while frequently encountered postoperative complications are corneal edema and anterior chamber reaction. Preoperative ACD and LT have no role in predicting intraoperative complications.</p>","PeriodicalId":18740,"journal":{"name":"Middle East African Journal of Ophthalmology","volume":"30 3","pages":"129-135"},"PeriodicalIF":0.5,"publicationDate":"2024-09-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11495291/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142504336","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Retinopathy of Prematurity in Extreme Preterm and Extreme Low-birth-weight Infants: Incidence, Course, and Risk Factors. 极早产儿和极低出生体重儿的早产儿视网膜病变:发病率、病程和风险因素。
IF 0.5 Q4 OPHTHALMOLOGY Pub Date : 2024-09-13 eCollection Date: 2023-07-01 DOI: 10.4103/meajo.meajo_15_24
T Lekha, Divya Balakrishnan, A Giridhar, Divya Alex, Anubhav Goyal

Purpose: The purpose of this study was to analyze the incidence of retinopathy of prematurity (ROP), treatment requiring ROP (TROP), course, and systemic risk factors in extreme preterm or extreme low-birth-weight babies.

Methods: A retrospective analysis of neonatal intensive care unit-based ROP screening from January to December 2021 in a tier-2 city in Kerala, India, was done. Inclusion criteria were gestational age (GA) ≤28 weeks or birth weight ≤1000 g. ROP screening and treatment were done according to the International Classification of ROP guidelines. Treatment was indicated in babies with type 1 ROP or aggressive ROP. Details of ROP screening, treatment, and neonatal risk factors were collected from the records. The results were statistically analyzed, and P < 0.05 was considered statistically significant.

Results: The study included 54 babies with a mean GA of 27.47 ± 1.76 weeks and a mean BW of 847.43 ± 189.22 g. ROP was detected at an average postmenstrual age of 33.8 ± 1.7 weeks. The incidence of any ROP and TROP was 87% and 19.14%, respectively. All babies with TROP were managed with laser or intravitreal antivascular endothelial growth factor injection or both. ROP resolved spontaneously in 60%, but those with Zone 2 disease had delayed regression. Inotropic support and anemia were found to increase the risk for ROP.

Conclusion: The incidence and outcome of any ROP and TROP in this study are comparable to the rates reported globally, and this reflects the improvement in neonatal care. The use of inotropes and anemia may increase the risk for ROP and needs to be managed judiciously.

目的:本研究旨在分析极早产儿或极低出生体重儿的早产儿视网膜病变(ROP)发病率、需要ROP治疗(TROP)、病程和系统性风险因素:方法:对印度喀拉拉邦一个二线城市 2021 年 1 月至 12 月期间新生儿重症监护室的早产儿视网膜病变筛查进行了回顾性分析。纳入标准为胎龄(GA)≤28 周或出生体重≤1000 克。根据国际视网膜病变分类指南进行视网膜病变筛查和治疗。治疗适用于 1 型早产儿视网膜病变或侵袭性早产儿视网膜病变的婴儿。从记录中收集了有关视网膜病变筛查、治疗和新生儿风险因素的详细信息。研究结果经统计学分析,P < 0.05 为差异有统计学意义:研究共纳入 54 名婴儿,平均月龄(27.47±1.76)周,平均体重(847.43±189.22)克。任何 ROP 和 TROP 的发生率分别为 87% 和 19.14%。所有患有 TROP 的婴儿都接受了激光或玻璃体内抗血管内皮生长因子注射治疗,或两者兼用。60%的早产儿可自然消退,但患有2区疾病的早产儿消退延迟。研究发现,肌力支持和贫血会增加发生 ROP 的风险:结论:本研究中任何 ROP 和 TROP 的发生率和结果与全球报告的发生率相当,这反映了新生儿护理的改善。使用肌注药物和贫血可能会增加发生 ROP 的风险,因此需要谨慎处理。
{"title":"Retinopathy of Prematurity in Extreme Preterm and Extreme Low-birth-weight Infants: Incidence, Course, and Risk Factors.","authors":"T Lekha, Divya Balakrishnan, A Giridhar, Divya Alex, Anubhav Goyal","doi":"10.4103/meajo.meajo_15_24","DOIUrl":"https://doi.org/10.4103/meajo.meajo_15_24","url":null,"abstract":"<p><strong>Purpose: </strong>The purpose of this study was to analyze the incidence of retinopathy of prematurity (ROP), treatment requiring ROP (TROP), course, and systemic risk factors in extreme preterm or extreme low-birth-weight babies.</p><p><strong>Methods: </strong>A retrospective analysis of neonatal intensive care unit-based ROP screening from January to December 2021 in a tier-2 city in Kerala, India, was done. Inclusion criteria were gestational age (GA) ≤28 weeks or birth weight ≤1000 g. ROP screening and treatment were done according to the International Classification of ROP guidelines. Treatment was indicated in babies with type 1 ROP or aggressive ROP. Details of ROP screening, treatment, and neonatal risk factors were collected from the records. The results were statistically analyzed, and <i>P</i> < 0.05 was considered statistically significant.</p><p><strong>Results: </strong>The study included 54 babies with a mean GA of 27.47 ± 1.76 weeks and a mean BW of 847.43 ± 189.22 g. ROP was detected at an average postmenstrual age of 33.8 ± 1.7 weeks. The incidence of any ROP and TROP was 87% and 19.14%, respectively. All babies with TROP were managed with laser or intravitreal antivascular endothelial growth factor injection or both. ROP resolved spontaneously in 60%, but those with Zone 2 disease had delayed regression. Inotropic support and anemia were found to increase the risk for ROP.</p><p><strong>Conclusion: </strong>The incidence and outcome of any ROP and TROP in this study are comparable to the rates reported globally, and this reflects the improvement in neonatal care. The use of inotropes and anemia may increase the risk for ROP and needs to be managed judiciously.</p>","PeriodicalId":18740,"journal":{"name":"Middle East African Journal of Ophthalmology","volume":"30 3","pages":"136-140"},"PeriodicalIF":0.5,"publicationDate":"2024-09-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11495289/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142504333","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Childhood Myopic Foveoschisis in LRPAP1-associated Myopia. LRPAP1相关性近视中的儿童近视眼窝畸形。
IF 0.5 Q4 OPHTHALMOLOGY Pub Date : 2024-09-13 eCollection Date: 2023-07-01 DOI: 10.4103/meajo.meajo_151_23
Mohammad Almazyead, Abdullmajeed S Alfakhri, Sulaiman M Alsulaiman

This case reports the development of foveoschisis in a child with high myopia due to a homozygous LRPAP1 pathogenic variant. A 9-year-old girl with high myopia due to a homozygous mutation in the LRPAP1 gene and a history of retinal detachment repair in her right eye, presented on follow-up with progressive myopic foveoschisis in the left eye noted on optical coherence tomography. The schitic changes evolved into a lamellar macular hole and required vitrectomy. Postoperatively, stabilization of the condition was achieved. Myopic foveoschisis could develop in childhood in the setting of recessive LRPAP1 pathogenic variants. Long_term follow-up is needed to determine the natural history of early-onset myopic foveoschisis.

本病例报告了一名因 LRPAP1 基因同源变异而患有高度近视的儿童出现的眼窝裂伤。一名 9 岁女孩因 LRPAP1 基因同源突变而患有高度近视,右眼曾进行过视网膜脱离修复手术。裂孔病变演变为片状黄斑孔,需要进行玻璃体切除术。术后病情稳定。隐性 LRPAP1 致病变体可能会在儿童期出现近视性黄斑裂孔。需要进行长期随访,以确定早发近视眼窝沟封闭的自然史。
{"title":"Childhood Myopic Foveoschisis in LRPAP1-associated Myopia.","authors":"Mohammad Almazyead, Abdullmajeed S Alfakhri, Sulaiman M Alsulaiman","doi":"10.4103/meajo.meajo_151_23","DOIUrl":"10.4103/meajo.meajo_151_23","url":null,"abstract":"<p><p>This case reports the development of foveoschisis in a child with high myopia due to a homozygous LRPAP1 pathogenic variant. A 9-year-old girl with high myopia due to a homozygous mutation in the LRPAP1 gene and a history of retinal detachment repair in her right eye, presented on follow-up with progressive myopic foveoschisis in the left eye noted on optical coherence tomography. The schitic changes evolved into a lamellar macular hole and required vitrectomy. Postoperatively, stabilization of the condition was achieved. Myopic foveoschisis could develop in childhood in the setting of recessive LRPAP1 pathogenic variants. Long_term follow-up is needed to determine the natural history of early-onset myopic foveoschisis.</p>","PeriodicalId":18740,"journal":{"name":"Middle East African Journal of Ophthalmology","volume":"30 3","pages":"182-184"},"PeriodicalIF":0.5,"publicationDate":"2024-09-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11495285/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142504331","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Status of Health-care Systems for Diabetes Mellitus and Diabetic Retinopathy in Jordan: Stakeholders and Health-care Providers Survey. 约旦糖尿病和糖尿病视网膜病变医疗保健系统现状:利益相关者和医疗保健提供者调查。
IF 0.5 Q4 OPHTHALMOLOGY Pub Date : 2024-09-13 eCollection Date: 2023-07-01 DOI: 10.4103/meajo.meajo_37_23
Motasem Allatayfeh, Amjad Al Shdaifat, Silvio P Mariotti

Purpose: The purpose of the study was to evaluate the status of health services for diabetes mellitus (DM) and diabetic retinopathy (DR) in Jordan in terms of availability and accessibility by interviewing people engaged with health-care process including decision makers, professional providers, and community representatives.

Methods: This is a qualitative study where participants were invited to respond by direct interview to a standard questionnaire that is validated by the World Health Organization (WHO), "Tool for Assessment of Diabetic Retinopathy and DM Management Systems". The questionnaire casts out of the WHO Health Systems Framework concept, assessing the presence of programs, guidelines, health technology and workforce, health promotion, and financing of DM and DR care in Jordan.

Results: Forty-two participants were included. DM is considered as priority in Jordan, but no programs are implemented. National guidelines are present for DM but not for DR. Networking should be improved between different disciplines caring for DM and DR. Human resources for DM and DR care were found insufficient and inadequately distributed. Health technology is only present in major cities and central hospitals. There is no nationwide data on disease burden nor a screening program for DR. More collaborated efforts should be spent on health education and raising awareness among people living with diabetes about the risk of DR.

Conclusion: Advanced DM and DR care is not accessible to most people. Programmatic efforts from the government and NGOs must formulate a national action plan to reduce the human and financial impact of the disease in Jordan.

目的:本研究旨在通过采访参与医疗保健过程的人员(包括决策者、专业服务提供者和社区代表),从可用性和可及性的角度评估约旦糖尿病(DM)和糖尿病视网膜病变(DR)医疗服务的现状:这是一项定性研究,通过直接访谈的方式邀请参与者回答一份经世界卫生组织(WHO)验证的标准问卷--"糖尿病视网膜病变和 DM 管理系统评估工具"。该问卷以世界卫生组织卫生系统框架概念为基础,评估约旦在糖尿病和视网膜病变护理方面的计划、指南、卫生技术和劳动力、健康促进和融资情况:共有 42 人参与了问卷调查。约旦将 DM 视为优先事项,但未实施任何计划。约旦有针对糖尿病的国家指导方针,但没有针对肺结核的指导方针。不同学科之间应加强DM和DR护理的联系。DM 和 DR 护理人力资源不足,分布不均。只有大城市和中心医院才有医疗技术。没有关于疾病负担的全国性数据,也没有 DR 筛查计划。应加大合作力度,开展健康教育,提高糖尿病患者对 DR 风险的认识:大多数人无法获得高级糖尿病和 DR 护理。政府和非政府组织的计划努力必须制定一项国家行动计划,以减少该疾病在约旦造成的人力和财力影响。
{"title":"Status of Health-care Systems for Diabetes Mellitus and Diabetic Retinopathy in Jordan: Stakeholders and Health-care Providers Survey.","authors":"Motasem Allatayfeh, Amjad Al Shdaifat, Silvio P Mariotti","doi":"10.4103/meajo.meajo_37_23","DOIUrl":"10.4103/meajo.meajo_37_23","url":null,"abstract":"<p><strong>Purpose: </strong>The purpose of the study was to evaluate the status of health services for diabetes mellitus (DM) and diabetic retinopathy (DR) in Jordan in terms of availability and accessibility by interviewing people engaged with health-care process including decision makers, professional providers, and community representatives.</p><p><strong>Methods: </strong>This is a qualitative study where participants were invited to respond by direct interview to a standard questionnaire that is validated by the World Health Organization (WHO), \"Tool for Assessment of Diabetic Retinopathy and DM Management Systems\". The questionnaire casts out of the WHO Health Systems Framework concept, assessing the presence of programs, guidelines, health technology and workforce, health promotion, and financing of DM and DR care in Jordan.</p><p><strong>Results: </strong>Forty-two participants were included. DM is considered as priority in Jordan, but no programs are implemented. National guidelines are present for DM but not for DR. Networking should be improved between different disciplines caring for DM and DR. Human resources for DM and DR care were found insufficient and inadequately distributed. Health technology is only present in major cities and central hospitals. There is no nationwide data on disease burden nor a screening program for DR. More collaborated efforts should be spent on health education and raising awareness among people living with diabetes about the risk of DR.</p><p><strong>Conclusion: </strong>Advanced DM and DR care is not accessible to most people. Programmatic efforts from the government and NGOs must formulate a national action plan to reduce the human and financial impact of the disease in Jordan.</p>","PeriodicalId":18740,"journal":{"name":"Middle East African Journal of Ophthalmology","volume":"30 3","pages":"168-172"},"PeriodicalIF":0.5,"publicationDate":"2024-09-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11495288/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142504335","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Demographic Factors Associated with Presenting for Eye Evaluation in the Partnership for Research on Vaccines and Infectious Diseases in Liberia III Natural History Study of Ebola Virus Disease. 利比里亚疫苗和传染病研究合作项目 III 埃博拉病毒病自然史研究中与接受眼部评估相关的人口学因素》(Partnership for Research on Vaccines and Infectious Diseases in Liberia III Natural History Study of Ebola Virus Disease)。
IF 0.5 Q4 OPHTHALMOLOGY Pub Date : 2024-06-14 eCollection Date: 2023-04-01 DOI: 10.4103/meajo.meajo_53_21
Augustine C D Wallace, Robin D Ross, Kirstin Tawse, Ruth Nyain, Catherine Gargu, Deborah E Wentworth, Rachel J Bishop, Allen O Eghrari

Purpose: Survivors of Ebola virus disease (EVD) are at risk for ocular complications after infection. We sought to identify demographic factors associated with the likelihood to present for eye examination among Ebola survivors enrolled in a longitudinal natural history study of EVD.

Methods: The Partnership for Research on Vaccines and Infectious Diseases in Liberia (PREVAIL) III Ebola natural history study is a 5-year study that seeks to identify long-term sequelae of EVD, including ocular sequelae. All survivors enrolled in the PREVAIL parent study from June 2015 to March 2016 were asked to return for comprehensive eye examination through June 2016. Logistic regression was conducted using self-reported survivor status, age, gender, and distance from the hospital as covariates.

Results: A total of 1448 subjects enrolled in the parent PREVAIL III longitudinal cohort during the defined window, of which 1375 (95.0%) followed up for baseline eye examination. Ebola survivors (635/661, 96.1%) and adult close contacts (727/767, 94.8%) demonstrated a comparable likelihood for presenting for eye examination (odds ratio [OR] 0.68, 95% confidence interval [CI] 0.36-1.28). In an adjusted model, age over 50 (OR 10.2, 95% CI 1.35-77.3) and living outside Montserrado County (OR 0.18, 95% CI 0.10-0.33) were associated with the likelihood of presenting for a baseline comprehensive eye examination.

Conclusion: Most EVD survivors and their close contacts who enrolled during the study window presented for eye examinations. Older participants and those who lived closer to clinical facilities were most likely to present. Focused strategies accounting for these factors may assist with organizations planning survivor care in the setting of EVD.

目的:埃博拉病毒病(EVD)幸存者在感染后有可能出现眼部并发症。我们试图确定与参加埃博拉病毒病纵向自然史研究的埃博拉幸存者接受眼科检查的可能性相关的人口统计学因素:利比里亚疫苗和传染病研究合作组织(PREVAIL)III埃博拉病毒自然史研究是一项为期5年的研究,旨在确定埃博拉病毒的长期后遗症,包括眼部后遗症。所有在 2015 年 6 月至 2016 年 3 月期间参加 PREVAIL 母研究的幸存者都被要求在 2016 年 6 月之前再次接受全面眼科检查。以自我报告的幸存者状况、年龄、性别和与医院的距离作为协变量进行了逻辑回归:共有 1448 名受试者在规定时间内加入了 PREVAIL III 的母体纵向队列,其中 1375 人(95.0%)接受了基线眼科检查。埃博拉幸存者(635/661,96.1%)和成年密切接触者(727/767,94.8%)接受眼科检查的可能性相当(比值比 [OR] 0.68,95% 置信区间 [CI] 0.36-1.28)。在调整模型中,50 岁以上(OR 10.2,95% CI 1.35-77.3)和居住在蒙特塞拉多县以外(OR 0.18,95% CI 0.10-0.33)与接受眼科基线全面检查的可能性相关:结论:大多数在研究窗口期登记的 EVD 幸存者及其密切接触者都接受了眼科检查。年龄较大和居住地离临床机构较近的参与者最有可能接受检查。针对这些因素采取有针对性的策略,可帮助组织规划在发生 EVD 时对幸存者的护理。
{"title":"Demographic Factors Associated with Presenting for Eye Evaluation in the Partnership for Research on Vaccines and Infectious Diseases in Liberia III Natural History Study of Ebola Virus Disease.","authors":"Augustine C D Wallace, Robin D Ross, Kirstin Tawse, Ruth Nyain, Catherine Gargu, Deborah E Wentworth, Rachel J Bishop, Allen O Eghrari","doi":"10.4103/meajo.meajo_53_21","DOIUrl":"10.4103/meajo.meajo_53_21","url":null,"abstract":"<p><strong>Purpose: </strong>Survivors of Ebola virus disease (EVD) are at risk for ocular complications after infection. We sought to identify demographic factors associated with the likelihood to present for eye examination among Ebola survivors enrolled in a longitudinal natural history study of EVD.</p><p><strong>Methods: </strong>The Partnership for Research on Vaccines and Infectious Diseases in Liberia (PREVAIL) III Ebola natural history study is a 5-year study that seeks to identify long-term sequelae of EVD, including ocular sequelae. All survivors enrolled in the PREVAIL parent study from June 2015 to March 2016 were asked to return for comprehensive eye examination through June 2016. Logistic regression was conducted using self-reported survivor status, age, gender, and distance from the hospital as covariates.</p><p><strong>Results: </strong>A total of 1448 subjects enrolled in the parent PREVAIL III longitudinal cohort during the defined window, of which 1375 (95.0%) followed up for baseline eye examination. Ebola survivors (635/661, 96.1%) and adult close contacts (727/767, 94.8%) demonstrated a comparable likelihood for presenting for eye examination (odds ratio [OR] 0.68, 95% confidence interval [CI] 0.36-1.28). In an adjusted model, age over 50 (OR 10.2, 95% CI 1.35-77.3) and living outside Montserrado County (OR 0.18, 95% CI 0.10-0.33) were associated with the likelihood of presenting for a baseline comprehensive eye examination.</p><p><strong>Conclusion: </strong>Most EVD survivors and their close contacts who enrolled during the study window presented for eye examinations. Older participants and those who lived closer to clinical facilities were most likely to present. Focused strategies accounting for these factors may assist with organizations planning survivor care in the setting of EVD.</p>","PeriodicalId":18740,"journal":{"name":"Middle East African Journal of Ophthalmology","volume":"30 2","pages":"103-106"},"PeriodicalIF":0.5,"publicationDate":"2024-06-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11238926/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141616862","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Imaging-based Biomarkers as Predictors of Response to Anti-VEGF Therapy in Idiopathic Choroidal Neovascularization. 基于成像的生物标志物可预测特发性脉络膜新生血管对抗血管内皮生长因子疗法的反应。
IF 0.5 Q4 OPHTHALMOLOGY Pub Date : 2024-06-14 eCollection Date: 2023-04-01 DOI: 10.4103/meajo.meajo_173_21
Surbhi Agrawal, Rohan Chawla, Vishnu Todi, Rajpal Vohra, Shorya V Azad

Purpose: The purpose of this study was to identify biomarkers that predict the response of treatment-naive idiopathic choroidal neovascularization (iCNV) to anti-VEGF treatment.

Methods: Fourteen eyes diagnosed with iCNV underwent a dilated fundus examination, Swept Source Optical Coherence Tomography (SS-OCT) and Optical Coherence Tomography - Angiography (OCT-A), and were given an anti-VEGF injection. The same examinations were repeated at every follow-up visit. Analysis of the pre- and posttreatment images was done to identify possible biomarkers which were evaluated to check association with decreased need for multiple anti-VEGF injections.

Results: At presentation, 11 patients showed a compact pattern, while three patients showed an arborizing pattern on OCT angiography (P = 1). On follow-up imaging, seven patients showed a marked response, five patients showed a moderate response, and two patients showed a mild response to anti-VEGF injection. Among the seven patients showing a marked response, only one required a repeat injection (P = 0.03). On analysis of SS-OCT, a novel Retinal Pigment Epithelium (RPE) healing response was observed in posttreatment imaging of six patients (P = 0.59).

Conclusion: A "marked" response to the first anti-VEGF injection results in a more sustained response and is a positive prognostic factor. RPE healing response is an interesting observation that merits further evaluation. Morphology of neovascular membranes has no effect on long-term need for multiple anti-VEGF injections.

目的:本研究的目的是确定预测特发性脉络膜新生血管(iCNV)对抗病毒血管内皮生长因子治疗反应的生物标志物:14只确诊为特发性脉络膜新生血管(iCNV)的眼睛接受了散瞳眼底检查、扫瞄源光学相干断层扫描(SS-OCT)和光学相干断层扫描-血管造影(OCT-A),并注射了抗血管内皮生长因子。每次随访时都重复同样的检查。对治疗前和治疗后的图像进行分析,以确定可能的生物标志物,并对其进行评估,以检查是否与减少多次注射抗血管内皮生长因子的需要有关:结果:发病时,11 名患者的 OCT 血管造影显示为紧凑型,3 名患者的 OCT 血管造影显示为树枝型(P = 1)。随访造影显示,7 名患者对注射抗血管内皮生长因子有明显反应,5 名患者有中度反应,2 名患者有轻度反应。在出现明显反应的七名患者中,只有一人需要再次注射(P = 0.03)。根据 SS-OCT 分析,在六名患者的治疗后成像中观察到了新的视网膜色素上皮(RPE)愈合反应(P = 0.59):结论:对首次注射抗血管内皮生长因子的 "明显 "反应会导致更持久的反应,是一个积极的预后因素。RPE愈合反应是一个有趣的观察结果,值得进一步评估。新生血管膜的形态对多次注射抗血管内皮生长因子的长期需求没有影响。
{"title":"Imaging-based Biomarkers as Predictors of Response to Anti-VEGF Therapy in Idiopathic Choroidal Neovascularization.","authors":"Surbhi Agrawal, Rohan Chawla, Vishnu Todi, Rajpal Vohra, Shorya V Azad","doi":"10.4103/meajo.meajo_173_21","DOIUrl":"10.4103/meajo.meajo_173_21","url":null,"abstract":"<p><strong>Purpose: </strong>The purpose of this study was to identify biomarkers that predict the response of treatment-naive idiopathic choroidal neovascularization (iCNV) to anti-VEGF treatment.</p><p><strong>Methods: </strong>Fourteen eyes diagnosed with iCNV underwent a dilated fundus examination, Swept Source Optical Coherence Tomography (SS-OCT) and Optical Coherence Tomography - Angiography (OCT-A), and were given an anti-VEGF injection. The same examinations were repeated at every follow-up visit. Analysis of the pre- and posttreatment images was done to identify possible biomarkers which were evaluated to check association with decreased need for multiple anti-VEGF injections.</p><p><strong>Results: </strong>At presentation, 11 patients showed a compact pattern, while three patients showed an arborizing pattern on OCT angiography (P = 1). On follow-up imaging, seven patients showed a marked response, five patients showed a moderate response, and two patients showed a mild response to anti-VEGF injection. Among the seven patients showing a marked response, only one required a repeat injection (P = 0.03). On analysis of SS-OCT, a novel Retinal Pigment Epithelium (RPE) healing response was observed in posttreatment imaging of six patients (P = 0.59).</p><p><strong>Conclusion: </strong>A \"marked\" response to the first anti-VEGF injection results in a more sustained response and is a positive prognostic factor. RPE healing response is an interesting observation that merits further evaluation. Morphology of neovascular membranes has no effect on long-term need for multiple anti-VEGF injections.</p>","PeriodicalId":18740,"journal":{"name":"Middle East African Journal of Ophthalmology","volume":"30 2","pages":"63-67"},"PeriodicalIF":0.5,"publicationDate":"2024-06-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11238929/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141616865","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bilateral Retinal Infiltration and Ischemia as the First Presenting Sign of Chronic Myeloid Leukemia: A Case Report with Multimodal Imaging. 双侧视网膜浸润和缺血是慢性粒细胞白血病的首发症状:多模态成像病例报告。
IF 0.5 Q4 OPHTHALMOLOGY Pub Date : 2024-06-14 eCollection Date: 2023-04-01 DOI: 10.4103/meajo.meajo_69_23
Asma K Alzuabi, Tariq A Alanazi, Abdulmajeed Alkharashi, Khalid M Al-Qahtani, Abdulrahman F Albloushi

Chronic myeloid leukemia (CML) is a malignant proliferative disorder involving the bone marrow and lymphatic system. Retinal involvement is a rare form of presentation in patients with CML. We report a case of a 49-year-old woman who presented with an acute bilateral visual disturbance. Her initial visual acuity was 20/20 in both eyes. Fundus examination revealed multiple yellowish retinal infiltrates, vascular sheathing, and peripheral sclerosed blood vessels. Fundus fluorescein angiography revealed bilateral peripheral retinal ischemia. Optical coherence tomography of the macula showed varying sizes of hyperreflective lesions distributed within the inner and outer retinal layers and in the subretinal space. Systemic workup revealed marked leukocytosis, and bone marrow biopsy revealed CML. Patients with CML can rarely present with ocular symptoms. Early recognition and prompt referral are crucial in lifesaving.

慢性髓性白血病(CML)是一种累及骨髓和淋巴系统的恶性增生性疾病。视网膜受累是 CML 患者的一种罕见表现形式。我们报告了一例因急性双侧视力障碍而就诊的 49 岁女性病例。她最初的双眼视力为 20/20。眼底检查发现多处淡黄色视网膜浸润、血管鞘和周围硬化血管。眼底荧光素血管造影显示双侧周边视网膜缺血。黄斑的光学相干断层扫描显示,视网膜内外层和视网膜下间隙分布着大小不等的高反射病变。全身检查发现白细胞明显增多,骨髓活检显示患有慢性骨髓性白血病。CML 患者很少会出现眼部症状。早期识别和及时转诊对挽救生命至关重要。
{"title":"Bilateral Retinal Infiltration and Ischemia as the First Presenting Sign of Chronic Myeloid Leukemia: A Case Report with Multimodal Imaging.","authors":"Asma K Alzuabi, Tariq A Alanazi, Abdulmajeed Alkharashi, Khalid M Al-Qahtani, Abdulrahman F Albloushi","doi":"10.4103/meajo.meajo_69_23","DOIUrl":"10.4103/meajo.meajo_69_23","url":null,"abstract":"<p><p>Chronic myeloid leukemia (CML) is a malignant proliferative disorder involving the bone marrow and lymphatic system. Retinal involvement is a rare form of presentation in patients with CML. We report a case of a 49-year-old woman who presented with an acute bilateral visual disturbance. Her initial visual acuity was 20/20 in both eyes. Fundus examination revealed multiple yellowish retinal infiltrates, vascular sheathing, and peripheral sclerosed blood vessels. Fundus fluorescein angiography revealed bilateral peripheral retinal ischemia. Optical coherence tomography of the macula showed varying sizes of hyperreflective lesions distributed within the inner and outer retinal layers and in the subretinal space. Systemic workup revealed marked leukocytosis, and bone marrow biopsy revealed CML. Patients with CML can rarely present with ocular symptoms. Early recognition and prompt referral are crucial in lifesaving.</p>","PeriodicalId":18740,"journal":{"name":"Middle East African Journal of Ophthalmology","volume":"30 2","pages":"121-124"},"PeriodicalIF":0.5,"publicationDate":"2024-06-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11238932/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141616861","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Extranuclear DNA Variations in the Susceptibility of Glaucoma. 青光眼易感性中的核外 DNA 变异。
IF 0.5 Q4 OPHTHALMOLOGY Pub Date : 2024-06-14 eCollection Date: 2023-04-01 DOI: 10.4103/meajo.meajo_132_23
Sunil Kumar, Ranjeet Kaur, Manzoor A Malik, Dewang Angmo, Jasbir Kaur

Glaucoma is a leading cause of irreversible blindness worldwide which affects all age groups. It is often identified by high intraocular pressure, characteristic optic neuropathy, and vision loss. Due to multifactorial nature of glaucoma pathogenesis, the molecular events responsible for its precipitation are currently poorly understood. Mitochondrial DNA (mtDNA) variations which are inherited maternally are being closely studied in recent times to elucidate the effect on glaucoma. Mitochondrial genetic studies till date have found a possible link between Leber hereditary optic neuropathy loci and glaucoma but with conflicting views. Furthermore, whole mtDNA studies in glaucoma points at the involvement of oxidative phosphorylation complex I and specifically the NADH dehydrogenase 5 gene in glaucoma. This review focuses on identifying the potential genes and variations in the maternally inherited mtDNA which might be involved in glaucoma pathogenesis.

青光眼是导致全球不可逆失明的主要原因,影响着各个年龄段的人群。青光眼通常表现为高眼压、特征性视神经病变和视力丧失。由于青光眼的发病机制是多因素的,目前人们对导致其发生的分子事件还知之甚少。近来,人们正在对母体遗传的线粒体 DNA(mtDNA)变异进行深入研究,以阐明其对青光眼的影响。迄今为止,线粒体基因研究发现 Leber 遗传性视神经病变基因位点与青光眼之间可能存在联系,但观点不一。此外,有关青光眼的全 mtDNA 研究表明,氧化磷酸化复合体 I,特别是 NADH 脱氢酶 5 基因与青光眼有关。本综述的重点是确定可能与青光眼发病机制有关的母体遗传 mtDNA 中的潜在基因和变异。
{"title":"Extranuclear DNA Variations in the Susceptibility of Glaucoma.","authors":"Sunil Kumar, Ranjeet Kaur, Manzoor A Malik, Dewang Angmo, Jasbir Kaur","doi":"10.4103/meajo.meajo_132_23","DOIUrl":"10.4103/meajo.meajo_132_23","url":null,"abstract":"<p><p>Glaucoma is a leading cause of irreversible blindness worldwide which affects all age groups. It is often identified by high intraocular pressure, characteristic optic neuropathy, and vision loss. Due to multifactorial nature of glaucoma pathogenesis, the molecular events responsible for its precipitation are currently poorly understood. Mitochondrial DNA (mtDNA) variations which are inherited maternally are being closely studied in recent times to elucidate the effect on glaucoma. Mitochondrial genetic studies till date have found a possible link between Leber hereditary optic neuropathy loci and glaucoma but with conflicting views. Furthermore, whole mtDNA studies in glaucoma points at the involvement of oxidative phosphorylation complex I and specifically the NADH dehydrogenase <i>5</i> gene in glaucoma. This review focuses on identifying the potential genes and variations in the maternally inherited mtDNA which might be involved in glaucoma pathogenesis.</p>","PeriodicalId":18740,"journal":{"name":"Middle East African Journal of Ophthalmology","volume":"30 2","pages":"113-120"},"PeriodicalIF":0.5,"publicationDate":"2024-06-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11238935/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141616864","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Relationship between Pittsburgh Sleep Quality Index and Retinopathy in Diabetic Women. 匹兹堡睡眠质量指数与糖尿病女性视网膜病变之间的关系
IF 0.5 Q4 OPHTHALMOLOGY Pub Date : 2024-06-14 eCollection Date: 2023-04-01 DOI: 10.4103/meajo.meajo_178_23
Mehmet Coşkun

Purpose: To examine the relationship between the presence and severity of retinopathy in women with diabetes mellitus and sleep quality assessed using Pittsburgh Sleep Quality Index (PSQI).

Methods: Among 90 female patients with type 2 diabetes, 30 patients without retinopathy were classified into Group 1, 30 patients with nonproliferative diabetic retinopathy as Group 2, and 30 patients with proliferative diabetic retinopathy as Group 3. People who had a known sleep problem, had a history of using medication other than sleeping pills that would affect sleep, had lower or upper respiratory tract disease, had history of previous surgery, or were unable to answer the survey questions appropriately were excluded from the study.

Results: The mean age was 52.6 ± 6.18 years in Group 1, 55.15 ± 8.15 years in Group 2, and 60.35 ± 5.93 years in Group 3. While no statistical difference was observed between Groups 1 and 2 (P = 0.27), a statistical difference was observed between both Groups 1 and 3 (P = 0.01) and Groups 2 and 3 (P = 0.02). PSQI scores were found to be 5.10 ± 1.07 in Group 1, 7.30 ± 2.34 in Group 2, and 6.70 ± 1.21 in Group 3. In terms of these scores, there was a statistical difference between Group 1 and both Group 2 (P = 0.01) and Group 3 (P = 0.01), while no difference was observed between Groups 2 and 3 (P = 0.31).

Conclusion: Although the presence of retinopathy significantly impairs sleep quality in diabeticwomen, no relationship was found between the severity of retinopathy and impaired sleep quality.

目的:研究女性糖尿病患者视网膜病变的存在和严重程度与使用匹兹堡睡眠质量指数(PSQI)评估的睡眠质量之间的关系:在90名女性2型糖尿病患者中,30名没有视网膜病变的患者被分为1组,30名患有非增殖性糖尿病视网膜病变的患者被分为2组,30名患有增殖性糖尿病视网膜病变的患者被分为3组。研究排除了已知有睡眠问题、曾使用过安眠药以外会影响睡眠的药物、患有下呼吸道或上呼吸道疾病、曾有手术史或无法正确回答调查问题的患者:第一组的平均年龄为(52.6 ± 6.18)岁,第二组为(55.15 ± 8.15)岁,第三组为(60.35 ± 5.93)岁。第一组和第二组之间无统计学差异(P = 0.27),但第一组和第三组之间(P = 0.01)以及第二组和第三组之间(P = 0.02)存在统计学差异。第一组的 PSQI 分数为 5.10 ± 1.07,第二组为 7.30 ± 2.34,第三组为 6.70 ± 1.21。就这些分数而言,第一组与第二组(P = 0.01)和第三组(P = 0.01)之间存在统计学差异,而第二组和第三组之间没有差异(P = 0.31):结论:虽然视网膜病变会严重影响女性糖尿病患者的睡眠质量,但视网膜病变的严重程度与睡眠质量受损之间没有关系。
{"title":"Relationship between Pittsburgh Sleep Quality Index and Retinopathy in Diabetic Women.","authors":"Mehmet Coşkun","doi":"10.4103/meajo.meajo_178_23","DOIUrl":"10.4103/meajo.meajo_178_23","url":null,"abstract":"<p><strong>Purpose: </strong>To examine the relationship between the presence and severity of retinopathy in women with diabetes mellitus and sleep quality assessed using Pittsburgh Sleep Quality Index (PSQI).</p><p><strong>Methods: </strong>Among 90 female patients with type 2 diabetes, 30 patients without retinopathy were classified into Group 1, 30 patients with nonproliferative diabetic retinopathy as Group 2, and 30 patients with proliferative diabetic retinopathy as Group 3. People who had a known sleep problem, had a history of using medication other than sleeping pills that would affect sleep, had lower or upper respiratory tract disease, had history of previous surgery, or were unable to answer the survey questions appropriately were excluded from the study.</p><p><strong>Results: </strong>The mean age was 52.6 ± 6.18 years in Group 1, 55.15 ± 8.15 years in Group 2, and 60.35 ± 5.93 years in Group 3. While no statistical difference was observed between Groups 1 and 2 (<i>P</i> = 0.27), a statistical difference was observed between both Groups 1 and 3 (<i>P</i> = 0.01) and Groups 2 and 3 (<i>P</i> = 0.02). PSQI scores were found to be 5.10 ± 1.07 in Group 1, 7.30 ± 2.34 in Group 2, and 6.70 ± 1.21 in Group 3. In terms of these scores, there was a statistical difference between Group 1 and both Group 2 (<i>P</i> = 0.01) and Group 3 (<i>P</i> = 0.01), while no difference was observed between Groups 2 and 3 (<i>P</i> = 0.31).</p><p><strong>Conclusion: </strong>Although the presence of retinopathy significantly impairs sleep quality in diabeticwomen, no relationship was found between the severity of retinopathy and impaired sleep quality.</p>","PeriodicalId":18740,"journal":{"name":"Middle East African Journal of Ophthalmology","volume":"30 2","pages":"107-112"},"PeriodicalIF":0.5,"publicationDate":"2024-06-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11238934/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141616882","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Middle East African Journal of Ophthalmology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1